Nov 19 (Reuters) - Telesta Therapeutics Inc TST.TO :
* Announces results of the FDA advisory committee vote
* Says advisory committee voted 18 no to 6 yes, with no abstentions
* Results of FDA joint meeting of advisory committee to discuss safety and
efficacy of co's bla for mcna1
* Says FDA's prescription drug user fee act (pdufa) review goal date for mcna
is February 27, 2016
* Source text for Eikon urn:newsml:reuters.com:*:nPreG7bhXa
* Further company coverage TST.TO